Q-Line Biotech IPO
Q-Line Biotech is an NSE SME IPO is expected to be priced soon with an issue size of 70,53,200 shares(agg. up to ₹[.] Cr). The IPO opens on May 21, 2026 and closes on May 25, 2026, with a lot size is yet to be announced and a minimum investment is yet to be announced.
Q-Line Biotech Limited IPO
- IPO Dates
- May 21, 2026 – May 25, 2026
- Price band
- ₹0-0 per equity share
- Minimum Investment
- ₹0
- Issue size
- 70,53,200 shares(agg. up to ₹[.] Cr)
- Lot size
- 0
- Allotment Date
- May 26, 2026
- Listing
- May 29, 2026
- Listing At
- NSE SME
IPO timeline
-
May 21, 2026
Open Date
Upcoming
-
May 25, 2026
Close Date
Upcoming
-
May 26, 2026
Allotment Date
Upcoming
-
May 29, 2026
Listing Date
Upcoming
Q-Line Biotech IPO Essentials
Q-Line Biotech IPO Details
Q-Line Biotech IPO has a total issue size of 70,53,200 shares(agg. up to ₹[.] Cr) and will be listed on NSE SME. Price band & Lot size details are yet to be announced.
- Issue price
- ₹0-0 per equity share
- Lot size
- 0 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 70,53,200 shares(agg. up to ₹[.] Cr)
- Listing at
- NSE SME
- Listing date
- Registrar
- Purva Sharegistry (India) Pvt.Ltd.
- Lead manager
-
Hem Securities Ltd., Share India Capital Services Pvt.Ltd.
Q-Line Biotech IPO Details
- Retail Portion 35%
Q-Line Biotech IPO Documents
Q-Line Biotech IPO Analytics
Q-Line Biotech Valuations
Fundamentals
- Market Cap
- Cr.
Q-Line Biotech Financials( In Crs.)
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 455.49 | 339.25 | 251.58 |
| Revenue | 322.58 | 206.45 | 184.81 |
| Profit After Tax | 28.13 | 34.44 | 32.10 |
| Net Worth | 189.95 | 161.81 | 127.37 |
| Reserves & Surplus | 188.37 | 160.24 | 125.79 |
| Total Borrowing | 164.95 | 96.91 | 73.65 |
Q-Line Biotech Company & Offer Insights
About Q-Line Biotech
Founded in 2010, Q-Line Biotech Ltd. is involved in the development, manufacture and commercialization of various reagents (kits and POC devices) and consumables and manufacturing, importation, and supply of diagnostic instruments for different healthcare requirements.
Q-Line Biotech Ltd. has been providing diagnostic instruments and IVD products for different healthcare requirements since 2013 either directly or via our distributor(s) primarily to diagnostic service organizations, hospitals, and medical colleges.
Q-Line Biotech Ltd.'s manufacturing categories comprise indigenous manufacture of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others (POC Devices & Rapid Tests) and supply/ manufacture of in vitro diagnostics (IVD), pathology equipment and devices.
As of March 31, 2025, the company employed 313 permanent employees.
Q-Line Biotech Promoter(s)
Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty, Abhay Agrawal are the company's promoters of Q-Line Biotech.
Q-Line Biotech IPO Issue Objectives
- •
- To meet Working Capital requirements
- •
- Repayment of certain borrowing availed by the Company, in part or full
- •
- General corporate purposes
Contact Information
Contact Details
Q-Line Biotech
+91 522-2435570
298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh - 226012.
Registrar Contact Details
Purva Sharegistry India Pvt Ltd
+91-022-23018261/ 23016761
Frequently Asked Questions
Click any question to reveal the answer
Q-Line Biotech IPO is a book-built IPO worth ₹70,53,200 shares(agg. up to ₹[.] Cr). The price band is ₹0–₹0 per share. The IPO opens on May 21, 2026 and closes on May 25, 2026. It will be listed on NSE SME Platform. Purva Sharegistry (India) Pvt. Ltd. is the registrar.
The price band of Q-Line Biotech IPO is ₹0 to ₹0 per share.
The lot size of Q-Line Biotech IPO is 0 shares.
The minimum investment for Q-Line Biotech IPO is not announced yet .
Q-Line Biotech IPO opens on May 21, 2026 and closes on May 25, 2026.
The allotment date of Q-Line Biotech IPO is May 26, 2026.
Q-Line Biotech IPO is expected to be listed on May 29, 2026, on NSE SME Platform.
The Grey market premium (GMP) for Q-Line Biotech IPO indicates market sentiment and potential listing expectations based on unofficial trading activity.
Q-Line Biotech IPO valuation snapshot: P/E N/A, EPS ₹/-, P/B N/A, RoNW %, and market cap Cr.
To apply for Q-Line Biotech IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Q-Line Biotech IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Q-Line Biotech IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Q-Line Biotech IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Q-Line Biotech IPO allotment status on IPO Ji for quick and easy access.